A post-hoc analysis shows the biologic reduced fracture risk with similar adverse event rates across a range of renal function levels.
Patients may require closer monitoring two years after pausing treatment, researchers say.
The predictive performance of the calculator has been elucidated in a large overseas registry study.
Some children with X-linked hypophosphataemia are being treated under the Special Access Scheme as the sponsor seeks PBS listing.
An expert panel has evaluated the circumstances demanding surveillance and how it should be conducted.
Routine assessment of BMD should be considered in this patient population, paediatric endocrinologists suggest.
Although no causal link has been established, researchers say findings highlight the importance of monitoring cognitive function and bone loss in t…
It may be time to question the role of the bone-sparing therapy, say expert commentators.
For patients on a high dose it appears to be on a par with other well-known risk factors, authors say.
Researchers think serum levels might be useful biomarker in older patients.